Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diemai Tongshuan
- Development stage
- Unknown
- Lead developer
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Diemai Tongshuan is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Changchun University of Traditional Chinese Medicine, specifically designed for the treatment of ischemic stroke and its recovery phase. The preparation, typically administered in capsule form, is composed of several herbal ingredients, most notably *Pueraria lobata* (Kudzu root) and *Erigeron breviscapus* (Dengzhanxihua). Its primary therapeutic mechanism involves promoting blood circulation, resolving blood stasis, and dredging the meridians to restore neurological function. Pharmacologically, it has been shown to improve cerebral microcirculation, inhibit platelet aggregation, and reduce blood viscosity. Additionally, it may exert neuroprotective effects by modulating oxidative stress and inflammatory pathways associated with cerebral ischemia-reperfusion injury. It is widely utilized in clinical practice within China as a hospital-made preparation for patients suffering from cerebral infarction and its sequelae.
- Brand names
- Diemai Tongshuan
- Other names
- Diemai Tongshuan CapsuleDiemai Tongshuan JiaonangDiemai Tongshuan Wan
Beyond the preview
Go deeper on Diemai Tongshuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diemai Tongshuan.